Skip to main content
Back
Activeted-524125-2026

Pharmaceutical rebate agreement for Trientine via Open-House model

Conclusion of a non-exclusive pharmaceutical rebate agreement for the active substance Trientine (ATC code A16AX12) within an Open-House model according to § 130a para. 8 SGB V.

View original source

CONTRACTING AUTHORITY

Name

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

City

Erfurt

Country

DE

Website

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33600000, Pharmaceutical products.

ADDITIONAL DETAILS

EU Funded

Yes

Suitable for SMEs

No

Electronic Submission

not-allowed

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

790 days remaining

(LOT-0001)

Published

Download tender documentsDemo required

TENDER DOCUMENTS

Portal — LOT-0001

NON-RESTRICTED-DOCUMENT

Demo required

TED HTML — 524125-2026

HTML

Demo required

TED PDF — 524125-2026

PDF

Demo required

TED XML — 524125-2026

XML

Demo required
790 days remaining

Similar Tenders

Explore CPV 33

Pharmaceutical Discount Agreement for Oralair(R) (ATC V01AA02) via Open-House Model

Conclusion of a non-exclusive pharmaceutical discount agreement according to § 130a Abs. 8 SGB V for medicinal products with the trade name Oralair(R) (WHO ATC code: V01AA02) within an Open-House model.

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

·Erfurt
Deadline:August 31, 2028

Pharmaceutical Discount Agreements for Orylmyte(R) (Open-House Model)

Conclusion of non-exclusive pharmaceutical discount agreements according to § 130a Abs. 8 SGB V via an Open-House model for the pharmaceutical Orylmyte(R) (ATC code V01AA03).

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

·Erfurt
Deadline:August 31, 2028

Pharmaceutical rebate agreement for Ipratropium bromide (Open-House model)

Conclusion of a non-exclusive pharmaceutical rebate agreement according to § 130a para. 8 SGB V via an Open-House model for the active substance Ipratropium bromide (ATC code R03BB01).

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

·Erfurt
Deadline:September 30, 2027

Pharmaceutical discount agreement for Omalizumab via Open-House model

Conclusion of a non-exclusive pharmaceutical discount agreement for the active substance Omalizumab (ATC code R03DX05) according to § 130a para. 8 SGB V via an Open-House model.

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

·Erfurt
Deadline:September 30, 2027

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now